---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-007118"
form_type: "8-K"
ticker: "PETV"
cik: "0001512922"
company_name: "PetVivo Holdings, Inc."
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T16:00:23.973055+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PetVivo signs exclusive license for VetStem's PrecisePRP canine and equine products

## Summary
- Upfront license fee of $500,000; milestone payments up to $500,000 in $250,000 increments.
- PetVivo issues 1M shares valued at $1.0M and warrant for 250K shares at $1.25 exercise price.
- Royalties based on net sales; term expires later of 10 years after first commercial sale or last valid claim.
- Product is an off-the-shelf allogeneic freeze-dried PRP with consistent 4B platelets per vial; no blood draw required.

## SEC filing metadata
- accession: 0001493152-25-007118
- form_type: 8-K
- ticker: PETV
- cik: 0001512922
- company_name: PetVivo Holdings, Inc.
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512922/000149315225007118/0001493152-25-007118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512922/000149315225007118/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-007118
- JSON: https://secwatch.observer/filing/0001493152-25-007118.json
- Plain text: https://secwatch.observer/filing/0001493152-25-007118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.